National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts.org
Search Results

From the 1/7/2022 release of VAERS data:

Found 21,745 cases where Vaccine targets COVID-19 (COVID19) and Patient Died

Government Disclaimer on use of this data



Case Details

This is page 1294 out of 2,175

Result pages: prev   1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303   next


VAERS ID: 1262028 (history)  
Form: Version 2.0  
Age: 26.0  
Sex: Male  
Location: Foreign  
Vaccinated:2021-04-10
Onset:2021-04-10
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-04-27
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 3001655 / 1 - / OT

Administered by: Unknown       Purchased by: ?
Symptoms: Arterial haemorrhage, Hypovolaemic shock
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow), Hypovolaemic shock conditions (narrow), Dehydration (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-10
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: ENALAPRIL; CARVEDILOL
Current Illness: Duchenne muscular dystrophy; Endotracheal intubation; Percutaneous endoscopic gastrostomy; Respiration failure
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: ITMODERNATX, INC.MOD20210

Write-up: IN SHOCK; This regulatory authority case was reported by a physician and describes the occurrence of ARTERIAL HAEMORRHAGE, IN SHOCK and HYPOVOLAEMIC SHOCK, in a 26-year-old male patient who received mRNA-1273 (COVID 19 Vaccine Moderna) (batch no. 3001655) for COVID-19 vaccination. Concurrent medical conditions included Endotracheal intubation, Respiration failure, Percutaneous endoscopic gastrostomy and Duchenne muscular dystrophy. Concomitant products included ENALAPRIL and CARVEDILOL for an unknown indication. On 10-Apr-2021, the patient received first dose of mRNA-1273 (COVID 19 Vaccine Moderna) (Intramuscular) 1 dosage form in total. On 10-Apr-2021, the patient experienced ARTERIAL HAEMORRHAGE (IN SHOCK) (seriousness criterion death) and HYPOVOLAEMIC SHOCK (IN SHOCK) (seriousness criterion death). The patient died on 10-Apr-2021. The reported cause of death was Hypovolaemic shock and Arterial haemorrhage. It is unknown if an autopsy was performed. The action taken with mRNA-1273 (COVID 19 Vaccine Moderna) (Intramuscular) was unknown. For mRNA-1273 (COVID 19 Vaccine Moderna) (Intramuscular), the reporter did not provide any causality assessments. No treatment information was provided. Company comment: Limited information regarding the events has been provided at this time and a causal relationship cannot be excluded. There is also limited information with regards the conditions captured as history / current conditions and it is unclear if any of these are associated with the recorded events; Reported Cause(s) of Death: Hypovolaemic shock; Arterial haemorrhage


VAERS ID: 1262030 (history)  
Form: Version 2.0  
Age: 76.0  
Sex: Unknown  
Location: Foreign  
Vaccinated:2021-03-24
Onset:2021-03-29
   Days after vaccination:5
Submitted: 0000-00-00
Entered: 2021-04-27
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA - / 1 - / OT

Administered by: Unknown       Purchased by: ?
Symptoms: Cardiogenic shock, Myocardial infarction
SMQs:, Cardiac failure (narrow), Myocardial infarction (narrow), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Embolic and thrombotic events, arterial (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: AMLODIPINE - TABLETS; BENDROFLUAZIDE; ATENOLOL; VALSARTAN
Current Illness:
Preexisting Conditions: Comments: No medical history was provided by the reporter.
Allergies:
Diagnostic Lab Data:
CDC Split Type: MTMODERNATX, INC.MOD20210

Write-up: cardiogenic shock; myocardial infarction; This regulatory authority case was reported by a consumer and describes the occurrence of CARDIOGENIC SHOCK (cardiogenic shock) and MYOCARDIAL INFARCTION (myocardial infarction) in a 76-year-old patient of an unknown gender who received mRNA-1273 (COVID 19 Vaccine Moderna) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included AMLODIPINE (AMLODIPINE - TABLETS), BENDROFLUMETHIAZIDE (BENDROFLUAZIDE), ATENOLOL and VALSARTAN for an unknown indication. On 24-Mar-2021, the patient received first dose of mRNA-1273 (COVID 19 Vaccine Moderna) (Intramuscular) 1 dosage form. On 29-Mar-2021, the patient experienced CARDIOGENIC SHOCK (cardiogenic shock) (seriousness criterion death) and MYOCARDIAL INFARCTION (myocardial infarction) (seriousness criterion death). The reported cause of death was Cardiogenic shock and Myocardial infarction. It is unknown if an autopsy was performed. Treatment information was not provided. Company comment: Limited information regarding the events has been provided at this time and a causal relationship cannot be excluded. It is not clear if the sender''s comment of "side-effects are unexpected" was a specific statement that the captured events were not related so as reported causality retained as not provided.; Reporter''s Comments: Side-effects are unexpected. challenge; compatible Re-challenge: RO De-challenge; inconclusive Signs and symptoms: compatible Lab test: L0 Alternate explanation: present Outcome I 1 uncertain.; Sender''s Comments: Limited information regarding the events has been provided at this time and a causal relationship cannot be excluded. It is not clear if the sender''s comment of "side-effects are unexpected" was a specific statement that the captured events were not related so as reported causality retained as not provided.; Reported Cause(s) of Death: Cardiogenic shock; Myocardial infarction


VAERS ID: 1262034 (history)  
Form: Version 2.0  
Age: 70.0  
Sex: Male  
Location: Foreign  
Vaccinated:2021-03-28
Onset:2021-03-28
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-04-27
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 3001442 / 1 - / OT

Administered by: Unknown       Purchased by: ?
Symptoms: Arthralgia, Chills, Death, Fatigue, Headache, Myalgia, Nausea, Neuralgia
SMQs:, Rhabdomyolysis/myopathy (broad), Acute pancreatitis (broad), Peripheral neuropathy (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Eosinophilic pneumonia (broad), Arthritis (broad), Tendinopathies and ligament disorders (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Comments: No medical history information reported
Allergies:
Diagnostic Lab Data:
CDC Split Type: NLMODERNATX, INC.MOD20210

Write-up: Unknown cause of death; Nausea; Generalized joint pain; Neuralgia; Fatigue; Myalgia; Headache; Chills; This regulatory authority case was reported by a consumer and describes the occurrence of DEATH (Unknown cause of death), NEURALGIA (Neuralgia), ARTHRALGIA (Generalized joint pain), NAUSEA (Nausea), FATIGUE (Fatigue), MYALGIA (Myalgia), CHILLS (Chills) and HEADACHE (Headache) in a 70-year-old male patient who received mRNA-1273 (COVID 19 Vaccine Moderna) (batch no. 3001442) for COVID-19 vaccination. No medical history information reported. On 28-Mar-2021, the patient received first dose of mRNA-1273 (COVID 19 Vaccine Moderna) (unknown route) 1 dosage form. On 28-Mar-2021, the patient experienced CHILLS (Chills) (seriousness criterion medically significant). On 31-Mar-2021, the patient experienced HEADACHE (Headache) (seriousness criterion medically significant). On 01-Apr-2021, the patient experienced NEURALGIA (Neuralgia) (seriousness criterion medically significant), FATIGUE (Fatigue) (seriousness criterion medically significant) and MYALGIA (Myalgia) (seriousness criterion medically significant). On 02-Apr-2021, the patient experienced ARTHRALGIA (Generalized joint pain) (seriousness criterion medically significant). On 04-Apr-2021, the patient experienced NAUSEA (Nausea) (seriousness criterion medically significant). The patient died on an unknown date. The cause of death was not reported. It is unknown if an autopsy was performed. At the time of death, NEURALGIA (Neuralgia), ARTHRALGIA (Generalized joint pain), NAUSEA (Nausea), FATIGUE (Fatigue), MYALGIA (Myalgia), CHILLS (Chills) and HEADACHE (Headache) outcome was unknown. Action taken with mRNA-1273 in response to the events was not Applicable. Concomitant and treatment information not provided. Company comment:Limited information regarding the events has been provided at this time and a causal relationship cannot be excluded.; Sender''s Comments: Limited information regarding the events has been provided at this time and a causal relationship cannot be excluded; Reported Cause(s) of Death: Unknown cause of death


VAERS ID: 1264984 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-04-15
Onset:2021-04-16
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-04-27
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EW 4815 / UNK - / OT

Administered by: Other       Purchased by: ?
Symptoms: Cerebral haemorrhage, Death
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow), Haemorrhagic central nervous system vascular conditions (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-16
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: MARCOUMAR; THIAMAZOL
Current Illness: Atrial fibrillation; Basedow''s disease (Morbus Basedow, Thiamazol Therapie); Coagulation disorder (Factor 5 coagulation disorder,reported by daughter to the vaccinating physician only after the death); Heart insufficiency; Hypertension; Insulin-requiring type II diabetes mellitus; Thrombosis; Ulcus cruris (residual Ulcera cruris)
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: ATPFIZER INC2021447105

Write-up: suspected cerebral bleeding; Exitus letalis 1 day after Comirnaty vaccination; This is a spontaneous report from a contactable physician downloaded from the regulatory authority-WEB. The regulatory authority number is AT-BASGAGES-2021-22949. A 78-year-old female patient received BNT162B2 (COMIRNATY), intramuscular on 15Apr2021 (lot number: EW 4815; expiration date: 31Jul2021) as single dose for COVID-19 immunisation. Medical history included an ongoing coagulation disorder: factor 5 coagulation disorder, reported by daughter to the vaccinating physician only after the death; ongoing heart insufficiency; ongoing insulin-requiring type II diabetes mellitus; ongoing atrial fibrillation; ongoing Basedow''s disease: Morbus Basedow, Thiamazol Therapie; ongoing thrombosis; ongoing hypertension; and ongoing ulcus cruris: residual ulcera cruris. Concomitant medications included phenprocoumon (MARCOUMAR) and thiamazole; both taken for an unspecified indication, start and stop date were not reported. On 16Apr2021, the patient experienced death and cerebral bleeding: Exitus letalis, 1 day after vaccination with BioNTech Pfizer vaccine, suspected cerebral bleeding, medical autopsy required, several pre-existing risks. The patient died on 16Apr2021; an autopsy was performed results have not been provided. Sender Comment: BASGAGES-comment: Follow-up information requested. No follow-up attempts are needed. No further information is expected.; Reported Cause(s) of Death: Exitus letalis 1 day after Comirnaty vaccination; suspected cerebral bleeding


VAERS ID: 1264985 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-04-27
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Adverse event following immunisation
SMQs:

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 0000-00-00
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: AUPFIZER INC2021444537

Write-up: Adverse event following immunisation; This is a spontaneous report from a contactable other health professional via the regulatory authority. Regulatory authority report number is 536538. An 81-year-old female patient received bnt162b2 (COMIRNATY), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced adverse event following immunisation on an unspecified date with fatal outcome. The patient died on an unspecified date. It was not reported if an autopsy was performed. No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Reported Cause(s) of Death: Adverse event following immunisation


VAERS ID: 1264991 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-04-01
Onset:2021-04-02
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-04-27
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH ER9480 / 2 - / -

Administered by: Other       Purchased by: ?
Symptoms: Dyspnoea exertional, General physical health deterioration, Sudden death
SMQs:, Torsade de pointes/QT prolongation (broad), Arrhythmia related investigations, signs and symptoms (broad), Pulmonary hypertension (broad), Cardiomyopathy (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-05
   Days after onset: 3
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: ASAFLOW; CLOPIDOGREL; BIPRESSIL
Current Illness: Morbid obesity
Preexisting Conditions: Medical History/Concurrent Conditions: Abstains from alcohol (no alcoholism); Myocardial infarction; Non-tobacco user (no tobacco user); Treatment noncompliance (Bad medication compliance, tendency to refuse care); Treatment refused due to patient''s wishes
Allergies:
Diagnostic Lab Data:
CDC Split Type: BEPFIZER INC2021453637

Write-up: General physical health deterioration in the days following; Dyspnoea on effort; Sudden death; This is a spontaneous report from a contactable physician downloaded from the Regulatory Authority (RA)-WEB, regulatory authority number BE-FAMHP-DHH-N2021-87727. A 57-year-old male patient received the second dose of bnt162b2 (COMIRNATY, Batch/Lot Number: ER9480), via an unspecified route of administration on 01Apr2021 as a single dose for COVID-19 immunisation. Medical history included ongoing morbid obesity, myocardial infarction from an unknown date and not ongoing, no alcoholism, non-tobacco user and bad medication compliance, tendency to refuse care treatment noncompliance from an unknown date and unknown if ongoing. Concomitant medications included acetylsalicylic acid (ASAFLOW), clopidogrel and bisoprolol fumarate, perindopril arginine (BIPRESSIL), all taken for an unspecified indication, start and stop dates were not reported. This male patient with a history of myocardial infarction and a weight of 162 kg, was vaccinated on 01Apr2021 with Comirnaty (second dose administered) and died 5 days after vaccination (sudden death). The patient experienced general physical health deterioration in the days following, dyspnoea on effort and sudden death on 02Apr2021. The outcome of the events was fatal. The patient died on 05Apr2021. An autopsy was not performed. Reporter comment: Treatment: No - Evolution of ADR: death - Examinations no - ADR description: Alteration of general state in the following days (heteroanamnesis little contributory), dyspnea with mild effort. Sudden death on 05Apr2021, 5 days after vaccination. Patients with a history of myocardial infarction. No autopsy performed. No follow-up attempts are needed. No further information is expected.; Reporter''s Comments: Treatment - No Evolution of the ADR - Death Examinations - / ADR description - Alteration of general state in the following days (heteroanamnesis little contributory), dyspnea with mild effort. Sudden death on 05Apr2021, 5 days after vaccination. Patients with a history of myocardial infarction. No autopsy performed.; Reported Cause(s) of Death: general physical health deterioration; dyspnoea on effort; sudden death


VAERS ID: 1265003 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-02-09
Onset:2021-02-10
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-04-27
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EM0477 / 1 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Cardiac arrest, Death, Dehydration, Pyrexia, Vomiting
SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (broad), Acute pancreatitis (broad), Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Acute central respiratory depression (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Cardiomyopathy (broad), Respiratory failure (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Dehydration (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-02-14
   Days after onset: 4
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: QUETIAPIN ACTAVIS; ASPIRIN CARDIO; LAMOTRIGIN ACTAVIS
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Aortic valve stenosis; Femur fracture; Polyarthritis; Seizures; Small bowel resection; Stroke; Vascular dementia, with delirium
Allergies:
Diagnostic Lab Data:
CDC Split Type: CHPFIZER INC2021452636

Write-up: Death; dehydration; circulation/cardiac arrest; Fever; Vomiting; This is a spontaneous report received from a contactable physician via Agency Regulatory Authority. Regulatory authority report number CH-SM-2021-12970. An 86-year-old female patient received BNT162B2 (COMIRNATY), dose 1 via intramuscular on 09Feb2021 (Batch/Lot Number: EM0477) as single dose for COVID-19 immunisation. Medical history included vascular dementia moderate with BPSD (behavioral and psychological symptoms of dementia), moderate aortic valve stenosis Dec2019, focal epilepsy with recurrent secondary generalized seizures in status after stroke in 2014, Seronegative polyarthritis with dominant involvement of hand and finger joints, status after femur fracture in May 2020, status after small bowel segment resection by mechanic ileus 2015. Concomitant medications included quetiapine fumarate (QUETIAPIN ACTAVIS), acetylsalicylic acid (ASPIRIN CARDIO), lamotrigine (LAMOTRIGIN ACTAVIS), all taken for an unspecified indication, start and stop date were not reported. On 09Feb2021, she received a vaccination with BNT162B2 (first dose, batch number unknown). From 10Feb2021 she manifested fever and vomiting. The woman died on 14Feb2021 from dehydration after multiple vomiting and circulation/cardiac arrest. Further course not known. An autopsy was not performed. A causal relationship between Comirnaty and death, fever and vomiting was assessed as being unlikely. This case was reported as serious (fatal outcome). Sender''s comment: Fever and vomiting occurred in close temporal correlation (the day after) with Comirnaty vaccination, in an elderly polymorbid woman and with concomitant medications. The reporter reported that due to the state of dehydration given by fever and vomiting and cardiovascular arrest, the woman died 5 days after receiving the vaccination. An autopsy was not performed. Fever is known side effect for Comirnaty from monograph, vomiting is not. The attached Regulatory Authority monograph mentions vomiting as a known adverse reaction on Comirnaty (frequency <1-2%). Based on the available information, it is thought possible that the vaccine, by causing fever and vomiting, contributed to worsening the condition of the elderly woman, who was already known to have numerous comorbidities. No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: Circulation/cardiac arrest; fever; vomiting; Dehydration; death


VAERS ID: 1265004 (history)  
Form: Version 2.0  
Age: 69.0  
Sex: Male  
Location: Foreign  
Vaccinated:2021-04-15
Onset:2021-04-15
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-04-27
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EP 9605 / 1 - / OT

Administered by: Other       Purchased by: ?
Symptoms: Cardiac failure acute, Circulatory collapse, Myocardial infarction
SMQs:, Cardiac failure (narrow), Anaphylactic reaction (narrow), Myocardial infarction (narrow), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Torsade de pointes, shock-associated conditions (narrow), Hypovolaemic shock conditions (narrow), Toxic-septic shock conditions (narrow), Anaphylactic/anaphylactoid shock conditions (narrow), Hypoglycaemic and neurogenic shock conditions (narrow), Embolic and thrombotic events, arterial (narrow), Cardiomyopathy (broad), Hypersensitivity (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-15
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: ASPIRIN CARDIO
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Heart disorder
Allergies:
Diagnostic Lab Data:
CDC Split Type: CHPFIZER INC2021453383

Write-up: Development of chest pain, loss of consciousness and onset of death.; myocardial infarction; acute circulatory failure; This is a spontaneous report received from a contactable physician via Regulatory Authority, the regulatory authority. Regulatory authority report number CH-SM-2021-14653. A 69-year-old male patient received first dose of BNT162B2 (COMIRNATY, Batch/Lot Number: EP 9605) via intramuscular on 15Apr2021 as single dose for covid-19 immunisation. Medical history included previous heart disease. Concomitant medication included acetylsalicylic acid (ASPIRIN CARDIO). On 15Apr2021, patient received the first dose of BNT162B2. 5 hours later, at home, he experienced chest pain, loss of consciousness and died (15Apr2021). The autopsy reports revealed that "cardiomegaly, coronary artery disease with subtotal stenosis, fresh myocardial infarction as cause of acute circulatory failure". This case was assessed as serious with seriousness criterion results in death. A causality between death and BNT162B2 was reported as being unlikely by Regulatory Authority. The patient died on 15Apr2021. An autopsy was performed that revealed cardiac failure acute, cardiomegaly, coronary artery disease with subtotal stenosis, fresh myocardial infarction, acute circulatory failure and the reported cause of death was cardiac failure acute, myocardial infarction, acute circulatory failure. Outcome of the events was fatal. Regulatory Authority assessment: Death in temporal correlation with first vaccination with Comirnaty in elderly man with previous heart disease. Indeed, the autopsy showed cardiomegaly and subtotal coronary artery stenosis. The cause of death was myocardial infarction with acute circulatory failure. It is believed that there was only a temporal correlation with vaccination. At the current state of knowledge, there is no data in the literature regarding a possible association between Comirnaty and ischemic cardiac impairment (i.e., myocardial infarction), and the causal link is therefore considered unlikely (a judgment that does not exclude that with increasing knowledge of the safety of the vaccine a causal role of the same may be found).; Reported Cause(s) of Death: Cardiac failure acute; acute circulatory failure; fresh myocardial infarction; Autopsy-determined Cause(s) of Death: Cardiac failure acute; cardiomegaly; coronary artery disease with subtotal stenosis; coronary artery disease with subtotal stenosis; fresh myocardial infarction; acute circulatory failure


VAERS ID: 1265007 (history)  
Form: Version 2.0  
Age: 70.0  
Sex: Female  
Location: Foreign  
Vaccinated:2021-03-25
Onset:2021-03-25
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-04-27
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Influenza like illness, Pneumonia, Renal failure
SMQs:, Rhabdomyolysis/myopathy (broad), Acute renal failure (narrow), Retroperitoneal fibrosis (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (broad), Torsade de pointes, shock-associated conditions (broad), Hypovolaemic shock conditions (broad), Toxic-septic shock conditions (broad), Anaphylactic/anaphylactoid shock conditions (broad), Hypoglycaemic and neurogenic shock conditions (broad), Eosinophilic pneumonia (broad), Chronic kidney disease (narrow), Tumour lysis syndrome (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-04-02
   Days after onset: 8
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: CZPFIZER INC2021447162

Write-up: Pneumonia; Renal failure; Fever, pain of the whole body; This is a spontaneous report from a contactable consumer downloaded from the Agency Regulatory Authority-WEB with regulatory authority number CZ-CZSUKL-21004242. A 70-year-old female patient received BNT162B2 (COMIRNATY; lot/batch number and expiration date not reported) via an unspecified route of administration on 25Mar2021 at a single dose for COVID-19 immunisation. The patient''s medical history and concomitant medications were not reported. The patient experienced fever, pain of the whole body, pneumonia, renal failure and death after vaccination with COMIRNATY on 25Mar2021. The patient was hospitalized for pneumonia and renal failure. Event fever, pain of the whole body was reported as serious, medically significant. Outcome of the event fever, pain of the whole body was not recovered. The patient died on 02Apr2021 due to pneumonia and renal failure. An autopsy was not performed. No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Reported Cause(s) of Death: Pneumonia; Renal failure


VAERS ID: 1265017 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-01-08
Onset:2021-01-08
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-04-27
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EM0477 / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Death, Fatigue, Pneumonia, Pyrexia, Respiration abnormal
SMQs:, Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Acute central respiratory depression (broad), Eosinophilic pneumonia (broad), Respiratory failure (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-01-18
   Days after onset: 10
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: LOSARTANKALIUM/HYDROCHLORTHIAZID "KRKA"; BUPRENORPHINE TEVA [BUPRENORPHINE HYDROCHLORIDE]; MUCOLYSIN [ACETYLCYSTEINE]; MOVICOL [MACROGOL 3350;POTASSIUM CHLORIDE;SODIUM BICARBONATE;SODIUM CHLORIDE]; PLAVIX; OXYNORM; PANODIL; CALCIUM AND VITA
Current Illness: Chronic obstructive airways disease; Dementia
Preexisting Conditions: Medical History/Concurrent Conditions: Constipation; Expectoration; Hypertension; Pain; Thrombosis prophylaxis; Vitamin supplementation
Allergies:
Diagnostic Lab Data:
CDC Split Type: DKPFIZER INC2021430029

Write-up: Pneumonia; affected respiration/abnormal breathing; Tiredness; Fever; unknown cause of death but maybe Chronic obstructive airways disease and from natural causes; This is a spontaneous report from a contactable physician downloaded from the Regulatory Authority-WEB with regulatory authority number DK-DKMA-WBS-0060972. A 95-year-old female patient received bnt162b2 (COMIRNATY), via an unspecified route of administration on 08Jan2021 (Lot Number: EM0477; Expiration Date: 30Apr2021) as a single dose for covid-19 immunisation. Medical history included ongoing dementia, ongoing chronic obstructive pulmonary disease, hypertension, expectoration (productive cough), constipation, thrombosis prophylaxis, pain and vitamin supplementation. Concomitant medications included hydrochlorothiazide, losartan potassium (LOSARTANKALIUM/HYDROCHLORTHIAZID "KRKA") therapy dates not reported for hypertension; buprenorphine hydrochloride (BUPRENORPHINE TEVA) for pain from 05Nov2020 to an unspecified stop date; acetylcysteine (MUCOLYSIN) for expectoration from 12Nov2020 to an unspecified stop date; macrogol 3350, potassium chloride, sodium bicarbonate, sodium chloride (MOVICOL) for constipation from 08Apr2020 to an unspecified stop date; clopidogrel bisulfate (PLAVIX) therapy dates not clearly reported (reported as start date unknown but at least since 23Jul2019) for thrombosis prophylaxis; oxycodone hydrochloride (OXYNORM) for pain from 07Oct2020 to an unspecified stop date; paracetamol (PANODIL) for pain from 05Oct2020 to an unspecified stop date; and calcium carbonate, ergocalciferol (CALCIUM AND VITAMIN D) for vitamin supplementation from 17Sep2020 to an unspecified stop date. The report received on 31mar2021 from a physician which describes the occurrence of abnormal breathing (affected respiration), fever (fever), pneumonia (pneumonia), tiredness (tiredness) in a 95 years old female patient vaccinated with COMIRNATY (tozinameran). On 08Jan2021, the patient developed fever, tiredness, abnormal breathing (affected respiration) and on 10Jan2021 pneumonia. The patient had unknown cause of death but maybe chronic obstructive airways disease and from natural causes on 18Jan2021. The Patient died on 18Jan2021 (not related to vaccination). There is no information regarding test results. The causality was reported as that the reporting physician does not suspect that side effects are related to the death of the patient. Stated that it is a coincidence and more likely related to the patient''s age and other illness. The outcome of the events respiration abnormal, fatigue, pyrexia and pneumonia were recovered in Jan2021 while the outcome of the other event was fatal. The patient died on 18Jan2021. It was not reported if an autopsy was performed. No follow-up attempts possible. No further information expected.; Sender''s Comments: Death with unknown cause is assessed related to BNT162B2 for reporting purpose. Case will be reassessed once receiving additional information, including cause of death. ; Reported Cause(s) of Death: unknown cause of death but maybe Chronic obstructive airways disease and from natural causes.


Result pages: prev   1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303   next

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=1294&VAX=COVID19&VAXTYPES=COVID-19&DIED=Yes


Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166